The global anti-peptic ulcer drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Anti-peptic ulcer drugs are among the various classes of drugs with different action mechanisms used to treat or reduce peptic ulcers or irritation of the gastrointestinal tract. Further, H. pylori, the spiral-shaped bacteria can damage the stomach and duodenum lining and cause peptic ulcer disease. The market growth is majorly attributed to the exceptionally growing prevalence of peptic ulcers all over the globe. As per the National Institutes of Health (NIH), about 30 to 40% of people in the US get an H. pylori infection. In most cases, the infection remains dormant, or quiet without signs or symptoms, for years. Most people get an H. pylori infection as a child.
To Request a Sample of our Report on Anti-Peptic Ulcer Drugs Market: https://www.omrglobal.com/request-sample/anti-peptic-ulcer-drugs-market
Another key trend observed in the market includes the growing preference of patients toward peptic ulcer drugs over surgeries. This is anticipated to be a major factor to augment the global anti-peptic ulcer drugs market during the forecast period. In addition to this, the increasing focus of the key players of the market on the research and development activities coupled with the rising number of generic drugs manufacturers of peptic ulcer drugs are also likely to offer lucrative opportunities for market growth. Further, stressed lifestyles, as well as a significant rise in the patient pool with H. pylori infection, will also raise the demand for these drugs in the future years.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Product Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: AstraZeneca plc, and Takeda Pharmaceutical Co., Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Anti-Peptic Ulcer Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-peptic-ulcer-drugs-market
Global Anti-Peptic Ulcer Drugs Market Report by Segment
By Product Type
- Proton Pump Inhibitors
- Antacids
- Potassium-Competitive Acid Blockers (P-CAB)
- H2 Antagonist
- Others
By Application
- Gastritis
- Gastric Ulcers
- Duodenal Ulcers
- Gastroesophageal Reflux Disease (GERD)
Global Anti-Peptic Ulcer Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
